FR2189034A2 - - Google Patents
Info
- Publication number
- FR2189034A2 FR2189034A2 FR7321743A FR7321743A FR2189034A2 FR 2189034 A2 FR2189034 A2 FR 2189034A2 FR 7321743 A FR7321743 A FR 7321743A FR 7321743 A FR7321743 A FR 7321743A FR 2189034 A2 FR2189034 A2 FR 2189034A2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2189034A2 true FR2189034A2 (da) | 1974-01-25 |
| FR2189034B2 FR2189034B2 (da) | 1977-01-21 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7321743A Expired FR2189034B2 (da) | 1972-06-15 | 1973-06-14 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (da) |
| CA (1) | CA1040619A (da) |
| DE (1) | DE2330342A1 (da) |
| DK (1) | DK136157B (da) |
| FR (1) | FR2189034B2 (da) |
| GB (1) | GB1434919A (da) |
| LU (1) | LU67790A1 (da) |
| NL (1) | NL7308267A (da) |
| ZA (1) | ZA734037B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2909546C (en) | 2013-04-17 | 2019-01-22 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| EP3868382A1 (en) | 2013-07-19 | 2021-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| DK3488852T3 (da) | 2013-08-23 | 2021-02-01 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser deraf |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| SI3206493T1 (sl) | 2014-10-16 | 2020-10-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| EP3206494A4 (en) | 2014-10-16 | 2018-07-04 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| PL3224269T3 (pl) | 2014-11-27 | 2020-08-24 | Sage Therapeutics, Inc. | Kompozycje i sposoby leczenia zaburzeń OUN |
| SI3250210T1 (sl) | 2015-01-26 | 2021-07-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| WO2016134301A2 (en) | 2015-02-20 | 2016-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| WO2018013615A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| PE20230244A1 (es) | 2019-05-31 | 2023-02-07 | Sage Therapeutics Inc | Esteroides neuroactivos y composiciones de estos |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118117A1 (da) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118123A1 (da) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118117A1 (da) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118123A1 (da) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1434919A (en) | 1976-05-12 |
| DE2330342A1 (de) | 1974-01-17 |
| DK136157C (da) | 1978-01-23 |
| LU67790A1 (da) | 1973-08-16 |
| ZA734037B (en) | 1974-05-29 |
| DK136157B (da) | 1977-08-22 |
| BE800899R (fr) | 1973-12-14 |
| NL7308267A (da) | 1973-12-18 |
| AU5693773A (en) | 1974-12-19 |
| FR2189034B2 (da) | 1977-01-21 |
| CA1040619A (en) | 1978-10-17 |